Nmn transporter slc12a8 and the future of nmn clinical trials with dr alessia grozio
THE NEED FOR NMN CLINICAL TRIALS
COLLABORATIONS ON NMN CLINICAL RESEARCH
One such collaboration we recently highlighted was the the work between aging research leader the Buck Institute, Elevant, and its parent company Seneque.
Together they have developed a healthy pipeline of NMN clinical trials in humans, which will focus on muscle recovery after exercise, potential benefits to skin health and much more (details in our interview).
Today, we host Elevant’s Chief Scientist and Buck Institute Researcher Dr. Alessia Grozio (PhD) for an exclusive interview on the future clinical trial outlook for NMN.